Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.
Comín-Colet J, Manito N, Segovia-Cubero J, Delgado J, García Pinilla JM, Almenar L, Crespo-Leiro MG, Sionis A, Blasco T, Pascual-Figal D, Gonzalez-Vilchez F, Lambert-Rodríguez JL, Grau M, Bruguera J; LION-HEART Study Investigators.
Comín-Colet J, et al.
Eur J Heart Fail. 2018 Jul;20(7):1128-1136. doi: 10.1002/ejhf.1145. Epub 2018 Feb 6.
Eur J Heart Fail. 2018.
PMID: 29405611
Clinical Trial.